A detailed history of Pictet Asset Management Holding Sa transactions in Biogen Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 1,014,278 shares of BIIB stock, worth $235 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
1,014,278
Previous 1,257,959 19.37%
Holding current value
$235 Million
Previous $326 Million 32.81%
% of portfolio
0.24%
Previous 0.36%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$212.02 - $267.71 $51.7 Million - $65.2 Million
-243,681 Reduced 19.37%
1,014,278 $219 Million
Q4 2023

Feb 13, 2024

BUY
$222.59 - $267.94 $10.1 Million - $12.2 Million
45,477 Added 3.75%
1,257,959 $326 Million
Q3 2023

Nov 14, 2023

BUY
$253.3 - $285.89 $307 Million - $347 Million
1,212,482 New
1,212,482 $312 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $33.4B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Pictet Asset Management Holding Sa Portfolio

Follow Pictet Asset Management Holding Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Holding Sa with notifications on news.